Apollo Hybrid Value Funds to invest in PanAsia Health’s HMI

Apollo announced that funds within its Hybrid Value strategy have committed to invest in PanAsia Health Limited, the holding company for Health Management International, a Singapore-headquartered regional healthcare provider. This investment continues the strong pace of activity of Apollo’s Hybrid Value strategy, which has led more than $18 billion of investment commitments since inception. HMI was founded in 1998 and is a fast-growing regional healthcare provider committed to advancing healthcare and changing lives for communities across Southeast Asia. Its two hospitals in Malaysia, Mahkota Medical Centre and Regency Specialist Hospital, are known for their clinical quality and breadth of specialties and subspecialties. The Group has also further expanded its healthcare platform through investments in Singapore, including the first private one-stop ambulatory care centre, StarMed Specialist Centre, the largest private ophthalmology chain in the country, Eagle Eye Centre, a nationwide primary care clinic chain, OneCare Medical, and the leading medical benefits administrator, MHC Asia Group. Proceeds from the investment will support HMI’s growth strategy as the Group seeks to invest in high quality healthcare businesses to continue its expansion in Southeast Asia. Apollo’s Hybrid Value team was able to create a flexible solution which aligned with the goals of HMI’s shareholders and management tea